Rating History for Sutro Biopharma (STRO) by Piper Sandler
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/16/2025 | Edward Tenthoff | Upgrade | Overweight (Neutral) |
2.00 (N/A) |
0.81 (25.29) |
3022.22% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 6/16/2025 | Edward Tenthoff | Upgrade | Overweight (Neutral) |
2.00 (N/A) |
0.81 (25.29) |
3022.22% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||